Potential for clinical pancreatic islet xenotransplantation

References

• American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36(4):1033–1046.
   PubMed Web of Science ®Google Scholar
• Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2014;383(9922):1084–1094.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–1786.
   PubMed Web of Science ®Google Scholar
• Golubnitschaja O. Advanced diabetes care: three levels of prediction, prevention and personalized treatment. Curr Diabetes Rev. 2010;6(1):42–51.
   Google Scholar
• Scheen AJ, Van Gaal LF. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes. Lancet Diabetes Endocrinol. Epub February 19, 2014.
   Google Scholar
• Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE. Pancreas and islet transplantation in type 1 diabetes. Diabetes Care. 2006;29(4):935.
   Web of Science ®Google Scholar
• Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia. 2008;51(1):120–129.
   Web of Science ®Google Scholar
• Keen H, Glynne A, Pickup JC, et al. Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet. 1980;2(8191):398–401.
   Web of Science ®Google Scholar
• Sutherland DE, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes. 1989;38 Suppl 1:85–87.
   Google Scholar
• Stegall MD, Lafferty KJ, Kam I, Gill RG. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation. 1996;61(8):1272–1274.
   Web of Science ®Google Scholar
• Koulmanda M, Qipo A, Smith RN, Auchincloss H Jr. Pig islet xenografts are resistant to autoimmune destruction by non-obese diabetic recipients after anti-CD4 treatment. Xenotransplantation. 2003;10(2):178–184.
   Web of Science ®Google Scholar
• Bai L, Tuch BE, Hering B, Simpson AM. Fetal pig beta cells are resistant to the toxic effects of human cytokines. Transplantation. 2002;73(5):714–722.
   Web of Science ®Google Scholar
• Lorenzo A, Razzaboni B, Weir G, Yankner BS. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994;368(6473):756–760.
   Web of Science ®Google Scholar
• Potter KJ, Abedini A, Marek P, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A. 2010;107(9):4305–4310.
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Bottino R, Kumar G, et al. Clinical islet xenotransplantation: how close are we? Diabetes. 2012;61(12):3046–3055.
   PubMed Web of Science ®Google Scholar
• Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet. 1994;344(8934):1402–1404.
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation. 2007;14(4):288–297.
   PubMed Web of Science ®Google Scholar
• Kirchhof N, Shibata S, Wijkstrom M, et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation. 2004;11(5):396–407.
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Marigliano M, He J, et al. Early islet damage after direct exposure of pig islets to blood: has humoral immunity been underestimated? Cell Transplant. 2012;21(8):1791–1802.
   PubMed Web of Science ®Google Scholar
• Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation. 2000;69(5):711–719.
   PubMed Web of Science ®Google Scholar
• Oriol R, Ye Y, Koren E, Cooper DK. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation. 1993;56(6):1433–1442.
   PubMed Web of Science ®Google Scholar
• Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in man. Transplant Proc. 1992;24(2):559–562.
   PubMed Web of Science ®Google Scholar
• Dor FJ, Cheng J, Alt A, Cooper DK, Schuurman HJ. Galα1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation. 2004;11(1):101–106.
   Web of Science ®Google Scholar
• Ekser B, Ezzelarab M, Hara H, et al. Clinical xenotransplantation: the next medical revolution? Lancet. 2012;379(9816):672–683.
   PubMed Web of Science ®Google Scholar
• Koike C, Friday RP, Nakashima I, et al. Isolation of the regulatory regions and genomic organization of the porcine α1,3-galactosyltransferase gene. Transplantation. 2000;70(9):1275–1283.
   Web of Science ®Google Scholar
• Koike C, Fung JJ, Geller DA, et al. Molecular basis of evolutionary loss of the α1,3-galactosyltransferase gene in higher primates. J Biol Chem. 2002;277(12):10114–10120.
   Google Scholar
• Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol. 2002;20(3):251–255.
   PubMed Web of Science ®Google Scholar
• Phelps CJ, Koike C, Vaught TD, et al. Production of α1,3-galactosyltransferase-deficient pigs. Science. 2003;299(5605):411–414.
   PubMed Web of Science ®Google Scholar
• Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med. 2005;11(1):29–31.
   PubMed Web of Science ®Google Scholar
• Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med. 2005;11(1):32–34.
   PubMed Web of Science ®Google Scholar
• Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med. 1995;1(9):964–969.
   PubMed Web of Science ®Google Scholar
• Roussel JC, Moran CJ, Salvaris EJ, Nandurkar HH, d’Apice AJ, Cowan PJ. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI. Am J Transplant. 2008;8(6):1101–1112.
   Web of Science ®Google Scholar
• Lee KF, Salvaris EJ, Roussel JC, Robson SC, d’Apice AJ, Cowan PJ. Recombinant pig TFPI efficiently regulates human tissue factor pathways. Xenotransplantation. 2008;15(3):191–197.
   Web of Science ®Google Scholar
• Crikis S, Lu B, Murray-Segal LM, et al. Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant. 2010;10(12):2586–2595.
   Web of Science ®Google Scholar
• Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med. 2006;12(3):301–303.
   PubMed Web of Science ®Google Scholar
• Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006;12(3):304–306.
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant. 2009;9(12):2716–2726.
   PubMed Web of Science ®Google Scholar
• Dufrane D, Goebbels RM, Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation. 2010;90(10):1054–1062.
   PubMed Web of Science ®Google Scholar
• Ayares D, Vaught T, Ball S, et al. Islet-specific expression of TFPI, CD39, and CTLA4Ig in transgenic pigs designed for xenoislet transplantation. Xenotransplantation. 2011;18(5):269.
   Web of Science ®Google Scholar
• Bottino R, Wijkstrom M, van der Windt DJ, et al. Pig to monkey xenotransplantation using multi-transgenic pigs. In press 2014.
   Google Scholar
• Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest. 1996;97(9):2119–2129.
   Web of Science ®Google Scholar
• Emamaullee JA, Shapiro AM, Rajotte RV, Korbutt G, Elliott JF. Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation. 2006;82(7):945–952.
   Web of Science ®Google Scholar
• Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation. 2011;18(6):328–342.
   Web of Science ®Google Scholar
• Elliott RB. Towards xenotransplantation of pig islets in the clinic. Curr Opin Organ Transplant. 2011;16(2):195–200.
   Web of Science ®Google Scholar
• Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet. 1998;352(9129):695–699.
   PubMed Web of Science ®Google Scholar
• Wynyard S, Nathu D, Garkavenko O, Denner J, Elliott R. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Xenotransplantation. Epub May 7, 2014.
   Google Scholar
• Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012;35(7):1436–1445.
   PubMed Web of Science ®Google Scholar
• Hering BJ, Cooper DKC, Cozzi E, et al. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes – executive summary. Xenotransplantation. 2009;16(4):196–202.
   Web of Science ®Google Scholar
• Onions D, Cooper DK, Alexander TJ, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation. 2000;7(2):143–155.
   PubMed Web of Science ®Google Scholar
• Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med. 1997;3(3):282–286.
   PubMed Web of Science ®Google Scholar
• Dieckhoff B, Petersen B, Kues WA, Kurth R, Niemann H, Denner J. Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation. 2008;15(1):36–45.
   Web of Science ®Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230–238.
   PubMed Web of Science ®Google Scholar
• Shapiro AM, Toso C, Imes S, et al. Five-year results of islet-alone transplantation match pancreas-alone transplantation with alemtuzumab, Tac/MMF, with strong suppression of auto and alloreactivity [abstract]. Rev Diab Stud. 2011;8:95–96.
   Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels: IDF; 2011.
   Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011. Atlanta: CDC; 2011. Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed July 10, 2014.
   Google Scholar